Concord Wealth Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3
| Closed | -$105 | – | 1151 |
|
|
2022
Q4 | $105 | Buy |
+3
| New | +$105 | ﹤0.01% | 1223 |
|
|
2022
Q3 | – | Sell |
-366
| Closed | -$19K | – | 788 |
|
|
2022
Q2 | $19K | Sell |
366
-1,401
| -79% | -$72.7K | 0.01% | 555 |
|
|
2022
Q1 | $128K | Sell |
1,767
-24
| -1% | -$1.74K | 0.03% | 258 |
|
|
2021
Q4 | $212K | Buy |
1,791
+1,322
| +282% | +$156K | 0.05% | 178 |
|
|
2021
Q3 | $63K | Sell |
469
-1,101
| -70% | -$148K | 0.03% | 182 |
|
|
2021
Q2 | $254K | Buy |
1,570
+241
| +18% | +$39K | 0.07% | 113 |
|
|
2021
Q1 | $107K | Buy |
1,329
+1,282
| +2,728% | +$103K | 0.04% | 206 |
|
|
2020
Q4 | $3K | Buy |
+47
| New | +$3K | ﹤0.01% | 481 |
|